Home/Filings/4/0001562180-23-006837
4//SEC Filing

Cardama Alfonso Quintas 4

Accession 0001562180-23-006837

CIK 0001822462other

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 4:01 PM ET

Size

5.6 KB

Accession

0001562180-23-006837

Insider Transaction Report

Form 4
Period: 2023-09-11
Cardama Alfonso Quintas
Chief Medical Officer
Transactions
  • Award

    Stock Options (Right to buy)

    2023-09-11$7.57/sh+272,000$2,059,040272,000 total
    Exercise: $7.57Exp: 2033-09-10Common Stock (272,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the underlying shares of common stock on September 11, 2024, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until the option is fully vested.

Issuer

Foghorn Therapeutics Inc.

CIK 0001822462

Entity typeother

Related Parties

1
  • filerCIK 0001760104

Filing Metadata

Form type
4
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 4:01 PM ET
Size
5.6 KB